Neoadjuvant Chemotherapy prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer: A Systematic Review

High-risk prostate cancer represents a pretentious clinical problem since a significant number of its patients will relapse and progress after radical prostatectomy. Neoadjuvant chemotherapy may be valuable since its efficacy in hormone-resistant prostate cancer has been established. In this paper,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sfoungaristos, Stavros, Kourmpetis, Vasileios, Fokaefs, Eleftherios, Perimenis, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594907/
https://www.ncbi.nlm.nih.gov/pubmed/23509625
http://dx.doi.org/10.1155/2013/386809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594907/
https://www.ncbi.nlm.nih.gov/pubmed/23509625
http://dx.doi.org/10.1155/2013/386809

Ejemplares similares